While many branded equivalents are stable for 21 days at room temperature, compounded versions may have a shorter window
SEC aggregation profiling
85% of participants Achieved an A1c of less than 7% Lost up to 10.6 kg (23.3 lbs) Improvements seen in 52 weeks Trial #5 Compared tirzepatide with placebo added to titrated insulin Glargine with or without metformin
Boehringer Ingelheim, the manufacturer, has advanced survodutide into Phase 3 trials for both obesity and metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH)
*Dependent on side effects experienced on the Wegovy pill
The monthly cost of Tirzepatide can vary depending on various factors, such as the dosage required, the duration of the treatment, and the patients insurance coverage